NGM BIOPHARMACEUTICALS INC — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$4.4M

Net Income/Loss (FY2023)

-$142.4M

Total Assets (FY2023)

$168.9M

Total Equity (FY2023)

$148.6M

Cash Flows from Operating Activities (FY2023)

-$132.2M

Source: NGM BIOPHARMACEUTICALS INC 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.